IllinoisHB3454104th General Assembly (2025–2026)HouseWALLET

EPINEPHRINE DELIVERY DEVICE

Sponsored By: Sponsor information unavailable

Signed by Governor

Summary

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

prescription drug affordability & accessibilityassignmentsinsurance

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

Lower epinephrine costs for children

For a covered person age 18 or under, qualifying health plans cap the payment for a medically necessary epinephrine twin-pack at $60. This applies to plans amended, delivered, issued, or renewed on or after January 1, 2020. The cap does not apply when it would make a high-deductible health plan lose health savings account eligibility.

More emergency epinephrine for children

Schools, camps, and after-school programs can use more FDA-approved forms of epinephrine. Trained, authorized people can give an undesignated system when they believe someone is having a severe allergic reaction, even without a prescription or diagnosed allergy. Schools and districts pay for the systems, and staff must complete required training. After school staff use a system, they must contact emergency services and a parent right away, notify the prescriber within 24 hours, and report to the State Board of Education within 3 days.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Camille Y. Lilly

    Democratic • House

  • Dagmara Avelar

    Democratic • House

  • Harry Benton

    Democratic • House

  • Janet Yang Rohr

    Democratic • House

  • Jawaharial Williams

    Democratic • House

  • Joyce Mason

    Democratic • House

  • Martha Deuter

    Democratic • House

  • Mary Edly-Allen

    Democratic • Senate

  • Michelle Mussman

    Democratic • House

  • Natalie A. Manley

    Democratic • House

  • Suzy Glowiak Hilton

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 320 • No: 0

House vote • 5/31/2026

Senate Floor Amendment No. 2 House Concurs

Yes: 116 • No: 0

House vote • 5/29/2026

Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee;

Yes: 13 • No: 0

Senate vote • 5/28/2026

Third Reading - Passed;

Yes: 59 • No: 0

Senate vote • 5/6/2026

Do Pass Insurance;

Yes: 9 • No: 0

House vote • 2/25/2026

Third Reading - Short Debate - Passed

Yes: 105 • No: 0

House vote • 2/11/2026

Approved for Consideration Rules Committee;

Yes: 5 • No: 0

House vote • 3/19/2025

Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee;

Yes: 13 • No: 0

Actions Timeline

  1. Public Act . . . . . . . . . 104-0762

    8/7/2026House
  2. Effective Date January 1, 2027

    8/7/2026House
  3. Governor Approved

    8/7/2026House
  4. Sent to the Governor

    6/26/2026House
  5. Passed Both Houses

    5/31/2026House
  6. House Concurs

    5/31/2026House
  7. Senate Floor Amendment No. 2 House Concurs 116-000-000

    5/31/2026House
  8. Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000

    5/29/2026House
  9. Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee

    5/29/2026House
  10. Added Chief Co-Sponsor Rep. Natalie A. Manley

    5/29/2026House
  11. Senate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee

    5/29/2026House
  12. Senate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason

    5/29/2026House
  13. Placed on Calendar Order of Concurrence Senate Amendment(s) 2

    5/28/2026House
  14. Arrived in House

    5/28/2026House
  15. Added as Alternate Co-Sponsor Sen. Mary Edly-Allen

    5/28/2026Senate
  16. Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)

    5/28/2026Senate
  17. Third Reading - Passed; 059-000-000

    5/28/2026Senate
  18. Placed on Calendar Order of 3rd Reading

    5/28/2026Senate
  19. Senate Floor Amendment No. 2 Adopted; Glowiak-Hilton

    5/28/2026Senate
  20. Recalled to Second Reading

    5/28/2026Senate
  21. Rule 2-10 Third Reading Deadline Established As May 31, 2026

    5/22/2026Senate
  22. Senate Floor Amendment No. 2 Be Approved for Consideration Assignments

    5/19/2026Senate
  23. Senate Floor Amendment No. 2 Referred to Assignments

    5/18/2026Senate
  24. Senate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton

    5/18/2026Senate
  25. Placed on Calendar Order of 3rd Reading May 18, 2026

    5/14/2026Senate

Bill Text

  • Engrossed

  • Enrolled

  • Introduced

  • Senate Amendment 1

  • Senate Amendment 2

Related Bills

Back to State Legislation